Biotech Values

[oc631]

Looking at alisporivir under current efficacy metrics makes this drug look quite underwhelming. Perhaps there's a slow building mechanism of action? The best drugs in the space knock the virus down below the LOD at 2-weeks with a 90%+ SVR rate.